|
|||||
|
|
The Combination of MK-5172, Peginterferon,and Ribavirin Is Effective in Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Infection Without Cirrhosis |
|
| Authors: | Michael P. Manns John M. Vierling Bruce R. Bacon Savino Bruno Oren Shibolet Yaacov Baruch Patrick Marcellin Luzelena Caro Anita Y.M. Howe Christine Fandozzi Jacqueline Gress Christopher L. Gilbert Peter M. Shaw Michael P. Cooreman Michael N. Robertson Peggy Hwang Frank J. Dutko Janice Wahl Niloufar Mobashery |
| Affiliation: | 1 Hannover Medical School, Hannover, Germany;2 Baylor College of Medicine, Houston, Texas;3 Saint Louis University, Saint Louis, Missouri;4 A. O. Fatebenefratelli and Oftalmico, Milan, Italy;5 Liver Unit, Department of Gastroenterology, Tel-Aviv Medical Center, Tel-Aviv, Israel;6 Liver Unit, Rambam Health Care Campus, Haifa, Israel;7 University Paris-Diderot, Clichy, France;8 Merck & Co, Inc, Whitehouse Station, New Jersey;9 German Center for Infection Research (DZIF), Hannover-Braunschweig, Germany |
| Abstract: | |
| Keywords: | Response-Guided Therapy Sustained Virologic Response Chronic HCV Protease Inhibitor |
| 本文献已被 ScienceDirect 等数据库收录！ | |